timothy sykes logo
Zynex’s Q3 2025 Financial Struggles: Dramatic Revenue Decline and Liquidity Concerns Thumbnail
ADD US ONG Google News

Zynex’s Q3 2025 Financial Struggles: Dramatic Revenue Decline and Liquidity Concerns

JACK KELLOGG•UPDATED NOV. 30, 2025, 8:05 AM ET
Reviewed by Tim Sykes Fact-checked by Ellis Hobbs

Zynex Inc.’s shares tumbled -19.5% following a sharp decline, boosted by concerns over regulatory challenges facing the company.

Healthcare industry expert:

Analyst sentiment – negative

Market Position & Fundamentals: Zynex, Inc. (ZYXI) is currently grappling with severe financial distress, as evidenced by its alarming profitability ratios such as an EBIT margin of -64.4% and a profit margin of -68.35%. The revenue has plummeted by 10.26% over the past three years, depicting a troubling trajectory. The negative book value per share (BVPS) at -1.36 and alarming net income figure, a loss of $42.9 million for Q3 2025, underscores the ongoing operational challenges. These metrics highlight significant management inefficiencies and a precarious market position, necessitating urgent strategic reassessment.

Technical Analysis & Trading Strategy: The recent price movement for ZYXI, from a high of 1.73 to 1.28, suggests a bearish trend. The price has been unable to sustain rallies, with significant resistance forming around the 1.60 level, where buyers have shown reluctance to push prices higher. A notable volume surge accompanied the price drop, signaling strong bearish sentiment. Traders are advised to consider short positions while price remains below the 1.50 resistance, targeting downside at 0.70 based on sustained bearish momentum and elevated selling pressure in short-term frames.

Catalysts & Outlook: Zynex’s recent news reveals an adverse financial landscape with substantial losses disrupting any positive momentum from the prior year. With revenues declining from $50 million to $13.4 million and a daunting liquidity situation, the delayed interest payment on convertible notes accentuates financial precariousness. Relative to industry peers in Healthcare and Medical Distributors, Zynex is notably underperforming, struggling with strategic misalignments. Facing pressing liquidity challenges, its inability to align with sector benchmarks demands an urgent turnaround plan, likely requiring outside intervention. Support is tentatively seen at 0.70, with resistance around 1.50, limiting near-term upside.

  • A significant downturn in profitability is evident, with a net loss of $42.9M compared to a net income of $2.3M reported in Q3 2024, signaling severe financial distress.

  • Liquidity challenges are intensifying, prompting engagement with financial advisors to explore strategic alternatives amidst the delay in interest payment of $1.5M on convertible notes.

Candlestick Chart

Weekly Update Nov 24 – Nov 28, 2025: On Sunday, November 30, 2025 Zynex Inc. stock [NASDAQ: ZYXI] is trending down by -19.5%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Zynex is currently navigating turbulent financial waters, underscored by a substantial reduction in revenue and significant net losses. The stark contrast between this year’s Q3 performance and the previous year highlights deteriorating financial health. This decline is alarming and signals that the company is struggling to maintain its market position. The financial ratios paint a dire picture, with negative profitability margins across the board, indicating that revenues are failing to cover basic costs and expenses.

Zynex’s gross margin remains relatively robust at 71.6%, suggesting some cost control over production. However, the negative pretax profit margin of -0.9% and a worrying profit margin contraction of -68.35% clearly forecast an uphill battle in achieving profitability soon. Additionally, a swift decrease in the stock price to as low as $0.7152, reflecting investors’ concerns over financial health, is notable. This turmoil manifests in Zynex’s quick and current ratios, markedly at 0.3 and 0.5 respectively, underscoring liquidity issues where current liabilities outweigh current assets, which could impede day-to-day operations.

The operating cash flow indicates a negative figure of -$6.3M, and stockholders’ equity sits at a troubling -$41.37M, reflecting the company’s struggle in generating returns on shareholder investments. Capital expenditures are notably low, pointing to limited reinvestment in the business, potentially stifling growth.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading ZYXI

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”